Thrombotic complications in essential thrombocythemia with relatively low platelet counts

American Journal of Hematology

Volumn 56, Issue 3, 1997, Pages 168-172

  Regev, Arie ^a   Stark, Pinhas ^a,b   Blickstein, Dorit ^a,b   Lahav, Meir ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

Essential thrombocythemia; Platelet counts; Thrombotic complications

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; FEMALE; HEADACHE; HEMOSTASIS; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOSIS; TINNITUS; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0030707621     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199711)56:3<168::AID-AJH6>3.0.CO;2-W     Document Type: Article

References (28)

1. Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S: Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 58:916, 1981.
2. Singal U, Prasad AS, Halton DM, Bishop C: Essential thrombocythemia: A clonal disorder of hematopoietic stem cell. Am J Hematol 14:193, 1983.
3. Epstein E, Godel A: Hämorrhagische thrombocythämie bei vasculärer schrumfmilz. Virchow's Arch 292:233, 1934.
4. Murphy S, Rosenthal DS, Weinfeld A, Briere J, Faguet GB, Knospe WH, Landaw SA, Laszlo J, Pisciotta AV, Tartaglia AP, Goldberg JD, Berk PD, Donovan PB, Wasserman LR: Essential thrombocythemia. Response during the first year of therapy with melphalan and radioactive phosphorus: A polycythemia vera study group report. Cancer Treat Rep 66:1495, 1982.
5. Rao AK, Carvalho ACA: Acquired qualitative platelet detects. In Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): "Hemostasis and Thrombosis: Basic Principles and Clinical Practice," Ed 3. Philadelphia: J.B. Lippincott Company, 1994, p 685.
6. Murphy S, Iland H, Rosenthal D, Laszlo J: Essential thrombocythemia: An interim report from the polycythemia vera study group. Semin Hematol 23:177, 1986.
7. Hehlmann R, Jahn M, Baumann B, Köpeke W: Essential thrombocythemia: Clinical characteristics and course of 61 cases. Cancer 61: 2487, 1988.
8. Kessler CM, Klein HG, Havlik RJ: Uncontrolled thrombocytosis in chronic myeloproliferative disorders. Br J Haematol 50:157, 1982.
9. Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T: Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8:556, 1990.
10. Van Genderen PJJ, Michiels JJ: Primary thrombocythemia: Diagnosis, clinical manifestations and management. Ann Hematol 67:57, 1993.
11. Case DC Jr: Therapy of essential thrombocythemia with thiotepa and chlorambucil. Blood 63:51, 1984.
12. Jabaily J, Iland HJ, Laszlo J, Massey EW, Faguet GB, Briére J, Landaw SA, Pisciotta V: Neurologic manifestations of essential thrombocythemia. Ann Intern Med 99:513, 1983.
13. Orlin JB, Berkman EM: Improvement of platelet function following plateletpheresis in patients with myeloproliferative disease. Transfusion 20:540, 1980.
14. Murphy S: Primary thrombocythemia. In Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): "Hematology," Ed 4. New York: McGraw-Hill, Inc., 1990, p 232.
15. Mitus AJ, Schafer AI: Thrombocytosis and thrombocythemia. Hematol Oncol Clin North Am 4:157, 1990.
16. Jandl JH: Chronic myeloproliferative syndromes. In Jandl JH (ed): "Textbook of Hematology," Ed 1. Boston: Little, Brown & Co., 1987, p 709.
17. Korenman G: Neurologic syndromes associated with primary thrombocythemia. J Mt Sinai Hosp 36:317, 1969.
18. Mitus AJ, Barbui T, Shulmun LN, Rosenthal DS, Viero P, Cortelazzo S, Schafer AI: Hemostatic complications in young patients with essential thrombocythemia. Am J Med 88:371, 1990.
19. Lahuerta-Palacios JJ, Bornstein R, Fernandez-Debora FJ, Gutiérrez- Rivas E, Ortiz MC, Larregla S, Calandre L, Montero-Castillo J: Controlled and uncontrolled thrombocytosis: Its clinical role in essential thrombocythemia. Cancer 61:1207, 1988.
20. Tefferi A, Hoagland CH: Issues in the diagnosis and management of essential thrombocythemia. Mayo Clin Proc 69:651, 1994.
21. Corteluzzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, Barbui T: Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 332:1132, 1995.
22. Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F: Clinical course of essential thrombocythemia in 147 cases. Cancer 66:549, 1990.
23. Schafer AI: Bleeding and thrombosis in the myeloproliferative disorders. Blood 64:1, 1984.
24. Kutti J: The management of thrombocytosis. Eur J Haematol 44:81, 1990.
25. Grossi A, Rosseti S, Vannucchi AM, Rafanelli D, Rossi Ferrini P: Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: A retrospective study of 108 patients. Clin Lab Haematol 10:167, 1988.
26. McIntyre KJ, Hoagland HC, Silverstein MN, Petitt RM: Essential thrombocythemia in young adults. Mayo Clin Proc 66:149, 1991.
27. Meisel S, Shpilberg O, Ramot B, Ben-bassat I: Essential thrombocythemia: A relative benign long-term course. Isr J Med Sci 29:190, 1993.
28. Pearson TC: Primary thrombocythemia: Diagnosis and management. Br J Haematol 78:145, 1991.